Alana Sadur

Ms. Alana Sadur

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2025 in Dermato
Verified
Journal Article
Open access
PDF file
ASAlana Sadur
Alana Sadur
LJLucie Joerg
Lucie Joerg
ADAmelia Grace Stapleton Van Doren
Amelia Grace Stapleton Van Doren
ELEllen Tse-Yi Lee
Ellen Tse-Yi Lee
DSDia Shah
Dia Shah
SCSonal Choudhary
Sonal Choudhary
Sleep is crucial to overall health and plays a significant role in skin function. While the circadian rhythm has been extensively researched for its impact on the body’s optimal functioning, the skin also possesses an independent circadian system that serves many important functions. Sleep disruptions or deprivation can significantly affect skin conditions, by compromising the skin barrier and impairing processes such as collagen production, cellular repair, and wound healing. Given the commonality of sleep disturbances, it is crucial to understand the connection between sleep, circadian regulation, and skin health. This is particularly important in understudied populations, such as those with occupational sleep disruption and individuals with hormone-related conditions like PCOS and menopause. Bidirectional relationships have been established between sleep and several inflammatory skin conditions, including atopic dermatitis, psoriasis, rosacea, and hidradenitis suppurativa. While acne is influenced by sleep, the reverse relationship, how acne affects sleep quality, has not been well established. Chronic sleep disruption can increase cortisol levels and oxidative stress, both of which contribute to skin aging and the progression of autoimmune skin conditions, including systemic lupus erythematosus. As sleep is a modifiable risk factor, it is crucial to consider therapeutic options and interventions to prevent or alleviate skin conditions. This review discusses various therapeutic approaches, including melatonin, L-Theanine, Magnesium-L-threonate, Inositol, Cinnamomi cortex, nervous system regulation, and proper sleep hygiene. These therapeutic options have been studied for their impact on sleep, and importantly, several have been evaluated for their utility as adjuncts for treating skin conditions. Overall, the relationship between sleep and skin health is clear, and incorporating sleep-focused therapeutic interventions offers potential to improve both sleep quality and skin health in individuals with a variety of skin conditions.

14 February 2023 in The American Surgeon™
Verified
Journal Article
Closed access
KMKeith D. Mortman
Keith D. Mortman
MTMira T. Tanenbaum
Mira T. Tanenbaum
KCKathryn M. Cavallo
Kathryn M. Cavallo
DKDevon Kelley
Devon Kelley
SBStephano S. Bonitto
Stephano S. Bonitto
MNMichael A. Napolitano
Michael A. Napolitano
Background: Prior studies suggest similar efficacy between large-bore chest tube (CT) placement and small-bore pigtail catheter (PC) placement for the treatment of pleural space processes. This study examined reintervention rates of CT and PC in patients with pneumothorax, hemothorax, and pleural effusion. Methods: This retrospective study examined patients from September 2015 through December 2020. Patients were identified using ICD codes for pneumothorax, hemothorax, or pleural effusion. Use of a pigtail catheter (≤14Fr) or surgical chest tube (≥20Fr) was noted. The primary outcome was overall reintervention rate within 30 days of tube insertion. Patients who died with a pleural drainage catheter in place, unrelated to complications from chest tube placement, were excluded. Results: There were 1032 total patients in the study: 706 CT patients and 326 PC patients. The PC group was older with more comorbidities and more likely to have effusion as the indication for pleural drainage. Patients with PC were 2.35 times more likely to have the tube replaced or repositioned ( P < .0001), 1.77 times more likely to require any reintervention ( P = .001) and 2.09 times more likely to remain in the hospital >14 days ( P < .0001) compared to patients with CT. Conclusion: PCs have a significantly higher reintervention rate compared to CT for the treatment of pneumothorax, hemothorax, and pleural effusion. Although PC are believed to cause less pain and tissue trauma, they do not necessarily drain the pleural space as well as CT. Decisions on which method of draining the chest should be made on a case-by-case basis.

18 February 2023 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
FCFrank R. Chen
Frank R. Chen
TQTheodore Quan
Theodore Quan
PRPradip Ramamurti
Pradip Ramamurti
ASAlana Sadur
Alana Sadur
STSean Tabaie
Sean Tabaie
ZZZachary R. Zimmer
Zachary R. Zimmer

1 December 2023 in JAAOS: Global Research and Reviews
Verified
Journal Article
Open access
ASAlana Sadur
Alana Sadur
CMCurt Martinez
Curt Martinez
SDSarah Dance
Sarah Dance
RTRyan Travers
Ryan Travers
AGAriana Gonzalez
Ariana Gonzalez
STSean A. Tabaie
Sean A. Tabaie
Introduction: Surveillance programs aimed at monitoring hip displacement in patients with cerebral palsy have been demonstrated to decrease the incidence of hip dislocations and properly time surgical intervention, ultimately improving patient outcomes. The objective of this study was to determine whether the implementation of a hip screening to surveillance program at a tertiary academic teaching hospital in 2017 increased the frequency of radiographic evaluations and changed the timing of surgical intervention. Methods: A total of 592 patients with cerebral palsy were identified, and 468 of these patients had initial radiograph date data available. In this analysis, 246 patients with initial radiograph dates after 2012 were included. The study population was divided into two groups based on the initial radiograph date, 2012 to 2016 versus 2017 to 2022. One hundred sixty patients (65%) were in the 2012 to 2016 group, and 86 (35%) were in the 2017 to 2022 group. Statistical analysis was conducted using various techniques, such as two-sample Student t-test, Mann-Whitney U test, chi square/Fisher exact test, and multivariable linear regression analysis. Results: The average number of radiographs per year in the 2017 to 2022 group was 0.11 (95% CI: 0.02, 0.20, P = 0.017) higher than the 2012 to 2016 group. After adjusting for confounders using multivariable linear regression analysis, this difference was even larger (difference 0.16, 95% CI: 0.06, 0.25, P = 0.001). The surgical intervention rate was significantly lower in the 2017 to 2022 group compared with the 2012 to 2016 group (12.9% versus 40.6%, P < 0.001). Discussion: The results of this study suggest that the implementation of a hip screening to surveillance program results in more frequent radiographic evaluations and possibly a reduced need for surgical intervention from 2017 to 2022. In the 2012 to 2016 group, more surgical interventions were performed likely because of the lack of any hip surveillance or screening program in place.

2 June 2026 in Dermato
Verified
Journal Article
Open access
PDF file
ACAlejandra Curbelo-Paz
Alejandra Curbelo-Paz
ELEllen Tse-Yi Lee
Ellen Tse-Yi Lee
ASAlana Sadur
Alana Sadur
NDNicholas D’Angelo
Nicholas D’Angelo
SCSonal Choudhary
Sonal Choudhary
Emerging research highlights the complex interplay between the gut microbiome, skin health, and environmental exposures, forming what is now recognized as the gut–skin–exposome axis. This narrative review explores the role of gut microbiome dysbiosis—a disruption in the balance of intestinal microorganisms—in the pathogenesis and progression of various non-communicable inflammatory skin diseases, including acne, atopic dermatitis, psoriasis, rosacea, systemic lupus erythematosus, chronic spontaneous urticaria, hidradenitis suppurativa, and alopecia areata. This review synthesizes mechanistic studies, clinical trials, and Mendelian randomization data to elucidate how altered gut microbial composition contributes to systemic and cutaneous inflammation. Key modifiable factors, such as diet, antibiotics, stress, and sleep, as well as interventions like probiotics, prebiotics, synbiotics, and fecal microbiota transplantation, are discussed for their potential therapeutic value. By integrating clinical insights with microbiome science, this review underscores the importance of a holistic, systems-based approach in managing inflammatory skin diseases, offering clinicians evidence-based strategies to improve patient outcomes through gut microbiome modulation.

1 April 2026 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
DCDaniel Carrera
Daniel Carrera
ASAlana Sadur
Alana Sadur
SESora Ely
Sora Ely
HKHenry Kaminski
Henry Kaminski
KMKeith Mortman
Keith Mortman
Background: Thymectomy had been an accepted treatment for myasthenia gravis (MG) for decades. Despite this, practice patterns of thymectomy for MG vary even though there is growing evidence of its safety and efficacy. This retrospective database study aimed to assess the safety of thymectomy for patients with nonthymomatous MG and to determine how surgical management of nonthymomatous MG changed following the 2016 publication of results from a phase 3, multicenter, randomized trial (MGTX trial) demonstrating thymectomy plus prednisone was superior to medical management alone. Methods: We retrospectively reviewed all thymectomy cases 2005–2023 in the National Surgical Quality Improvement Program (NSQIP) database. We compiled postoperative complications and mortality into broad and narrow composite outcomes to display adverse events associated with thymectomy in MG patients. We then used National Institutes of Health (NIH) Joinpoint models to indicate changes in annual rates of thymectomy (in general) and minimally invasive thymectomy (specifically) for MG between 2005–2023 pre- and post- publication of the MGTX trial. Results: The queried NSQIP database had a total of 352 nonthymomatous thymectomies performed on MG patients between 2005–2023. The odds of experiencing a broad composite outcome following thymectomy was 7.1% (N=25) and the odds of experiencing a narrow outcome was 3.1% (N=11). The data also showed that there were no 30-day mortalities. Annual percentage change (APC) of thymectomy and minimally invasive thymectomy for MG gradually increased until 2019 and 2020 (2.52% and 4.01% APC, respectively), before decreasing through 2023 (−10.79% APC, P=0.02, and −17.51% APC, P=0.27, respectively). Conclusions: Following the 2016 MGTX trial, thymectomy continues to be a safe procedure among MG patients. Despite this, the current study reveals limited adoption of thymectomy into practice as reflected by the predicted annual rate of thymectomy in MG patients.